Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.53
Shares Outstanding178.4M
Average Volume (10 days)977.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.44)
Sales (TTM)$8.24
Book Value (MRQ)$16.64
Cash Flow (TTM)$0.11
Cash (MRQ)$6.09

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy15
 
Buy1
 
Hold4
 
Underperform0
 
Sell0
 

Recent Insider Transactions

G. Eric Davis
EVP, General Counsel
(7,907)
Sell
Mar 19, 2019
Henry J. Fuchs
President, Worldwide R&D
(9,597)
Sell
Mar 18, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
34,780
Acquire
Mar 15, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(28,143)
Dispose
Mar 15, 2019
Robert A. Baffi
EVP, Technical Operations
(7,083)
Dispose
Mar 15, 2019

Recent SEC Filings

Insider Buy/Sell
Mar 25, 2019
Insider Buy/Sell
Mar 21, 2019
Insider Buy/Sell
Mar 21, 2019
Insider Buy/Sell
Mar 21, 2019
Insider Buy/Sell
Mar 19, 2019

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information